Final Results on Efficacy and Safety of Biosimilar Infliximab after One-Year: Results from a Prospective Nationwide Cohort
2017; Elsevier BV; Volume: 152; Issue: 5 Linguagem: Inglês
10.1016/s0016-5085(17)31554-8
ISSN1528-0012
AutoresK Gecse, Zsuzsanna Végh, Zsuzsanna Kürti, Mariann Rutka, Klaudia Farkas, Petra A. Golovics, Barbara D. Lovász, Lóránt Gönczi, J Banai, László Bene, Beáta Gasztonyi, Tünde Kristóf, L. Lakatos, Pál Miheller, Ferenc Nagy, Károly Palatka, Mária Papp, Árpád V. Patai, Á Salamon, T Szamosi, Zoltán Szepes, Gábor Tamás Tóth, Áron Vincze, Tamás Molnár, Péter L. Lakatos,
Tópico(s)Health Systems, Economic Evaluations, Quality of Life
ResumoTable 1.Course of the IFX
Referência(s)